Promethera Biosciences
Innovative biopharmaceuticals harnessing healthy human liver cells to treat liver diseases with groundbreaking stem cell technology.
11-50 employees · est. 2009
Promethera Biosciences is the older company (2019 vs 2009); Ensoma is the larger of the two.
1 signal in the last 90 days
Side-by-Side Comparison
| Metric | Ensoma | Promethera Biosciences |
|---|---|---|
| Founded | ||
| Founded | 2019 | 2009 older |
| Headquarters | ||
| Headquarters | Boston, United States | Not tracked yet |
| Employees | ||
| Employees | 51 larger | 11-50 |
| Industry | ||
| Industry | Biotechnology, Health and Wellness, Life Sciences | Biotechnology, Health and Wellness, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Unknown | Series D |
| Total Funding | ||
| Total Funding | $258.00M | $131.06M |
| Funding Rounds | ||
| Funding Rounds | 5 | 7 |
| Services | ||
| Services | In Vivo Hematopoietic Stem Cell Engineering, Gene Therapy Development, Delivery System for Genetic Modifications | Not tracked yet |
| Target Customers | ||
| Target Customers | Patients with Hematologic Disorders, Healthcare Providers, Pharmaceutical Researchers, Biotech Investors | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Genomic Medicine, In Vivo Treatments, Gene Modification, Immune Cell Engineering, Blood Cell Engineering, Engenious Vectors, Next-generation Therapies, One-time Treatments, Non-myeloablative Conditioning, Outpatient Healthcare, Off-the-shelf Biologics, Rare Disease Treatment, Precision Medicine, Genetic Engineering | Biopharmaceuticals, Cell Therapy, Liver Diseases, Stem Cell Technology, Regenerative Medicine, Chronic Liver Disease, NASH, ACLF, Fatty Liver, Clinical Stage, Liver-based Genetic Diseases, Innovative Treatments, Acquired Liver Diseases, Antibodies |
| Website | ||
| Website | ensoma.com | promethera.com |
About Ensoma
Ensoma, established in 2019, is pioneering a transformative approach in the Biotechnology, Health and Wellness, and Life Sciences sectors. Operating from the United States, Ensoma focuses on developing one-time in vivo treatments that aim to precisely engineer blood and immune cells to combat diseas...
About Promethera Biosciences
Promethera Biosciences is a biopharmaceutical firm founded in 2009 with a mission to harness healthy human liver cells to develop innovative treatments for liver diseases. The company, originating from the Université Catholique de Louvain, focuses on crafting advanced treatments utilizing allogeneic...
We will tell you when either one moves
BounceWatch watches Ensoma and Promethera Biosciences for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Ensoma and Promethera Biosciences — by email.
Frequently Asked Questions
Compare Ensoma with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Ensoma on 9 Jun 2026, and Promethera Biosciences on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.